204 related articles for article (PubMed ID: 29992422)
1. An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients.
Baalman SWE; Quast ABE; Brouwer TF; Knops RE
Curr Cardiol Rep; 2018 Jul; 20(9):72. PubMed ID: 29992422
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
5. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous or Transvenous Defibrillator Therapy.
Knops RE; Olde Nordkamp LRA; Delnoy PHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; van der Stuijt W; de Weger A; de Wilde KC; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Tijssen JGP; Wilde AAM;
N Engl J Med; 2020 Aug; 383(6):526-536. PubMed ID: 32757521
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
[TBL] [Abstract][Full Text] [Related]
12. Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis.
Nso N; Nassar M; Lakhdar S; Enoru S; Guzman L; Rizzo V; Munira MS; Radparvar F; Thambidorai S
Int J Cardiol; 2022 Feb; 349():62-78. PubMed ID: 34801615
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
[TBL] [Abstract][Full Text] [Related]
14. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
[TBL] [Abstract][Full Text] [Related]
15. Comparing the safety of subcutaneous versus transvenous ICDs: a meta-analysis.
Su L; Guo J; Hao Y; Tan H
J Interv Card Electrophysiol; 2021 Apr; 60(3):355-363. PubMed ID: 33432473
[TBL] [Abstract][Full Text] [Related]
16. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
[TBL] [Abstract][Full Text] [Related]
17. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
[TBL] [Abstract][Full Text] [Related]
18. The subcutaneous implantable cardioverter-defibrillator in review.
Kamp NJ; Al-Khatib SM
Am Heart J; 2019 Nov; 217():131-139. PubMed ID: 31654943
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
[TBL] [Abstract][Full Text] [Related]
20. Transvenous versus subcutaneous implantable cardioverter defibrillators in young cardiac arrest survivors.
Morton MB; Mariani JA; Kistler PM; Patel H; Voskoboinik A
Intern Med J; 2023 Nov; 53(11):1956-1962. PubMed ID: 37929818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
